Pura Vida Investments, LLC Sage Therapeutics, Inc. Call Options Transaction History

Pura Vida Investments, LLC

  • $145 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$60.18 - $154.77 $601,800 - $1.55 Million
-10,000 Closed
0 $0
Q3 2019

Feb 12, 2021
BUY
$140.29 - $189.96 $1.39 Million - $1.88 Million
9,900 Added 9900.0%
10,000 $1.4 Million
Q3 2019

Nov 14, 2019
BUY
$140.29 - $189.96 $14,029 - $18,996
100 New
100 $60,000

Others Institutions Holding SAGE

# of Institutions
198
Shares Held
46.5M
Call Options Held
402K
Put Options Held
209K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email